NCT05070247
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05070247
Title A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Takeda
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Univeristy of Alabama at Birmingham Birmingham Alabama 35294 United States Details
City of Hope Comprehensive Cancer Center Duarte California 91010 United States Details
University of California San Diego La Jolla California 92093 United States Details
University of Colorado - Anschutz Medical Campus - PPDS Aurora Colorado 80045 United States Details
Sarah Cannon Research Institute Denver Colorado 80218 United States Details
Sylvester Comprehensive Cancer Center Miami Florida 33136 United States Details
Northwestern Chicago Illinois 60611 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
New York University New York New York 10016-4744 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Sarah Cannon Cancer Institute Nashville Tennessee 37203 United States Details
START South Texas Accelerated Research Therapeutics San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field